ADHD and learning disabilities: Are high-fat diets to blame?

Are high-fat diets to blame for ADHD and learning disabilities Effect is so profound that eating lots of fatty food for even a WEEK can cause behavioural changes Thought that too much fat may alter how the body metabolises dopamine, a chemical responsible for mood By Anna Hodgekiss PUBLISHED: 17:52 GMT, 26 February 2013 | UPDATED: 18:15 GMT, 26 February 2013 A high-fat diet may be linked to the hyperactivity disorder ADHD and learning disabilities, new research suggests.

Epilim: Autism risk of drug taken by thousands of mums for epilepsy

Autism risk of drug taken by thousands of mums for epilepsy: Up to 17,500 children affected since 1973, researchers believeAs many as one in three children born to mothers taking Epilim affectedDrug taken by about 21,500 women of childbearing age to control seizuresFamilies campaigning for manufacturer to withdraw the drug By Sophie Borland PUBLISHED: 00:54 GMT, 4 February 2013 | UPDATED: 08:05 GMT, 4 February 2013 Dangers: Researchers have warned as many as one in three children born to mothers taking Epilim have developed autism or behavioural problems (file picture) An epilepsy drug taken by thousands of women has been linked to learning disabilities in children.

Fresh hope of vaccine for killer meningitis B that could prevent illness in 80% of children

Fresh hope of vaccine for killer meningitis B that could prevent illness in 80% of children | UPDATED: 00:36 GMT, 7 May 2012 New hope: The jab to protect againt Meningitis B proved successful in the majority of teenagers giving hope for future inoculations A jab to protect against deadly meningitis B is being developed by scientists.

New vaccine against deadly meningitis B "will be available in the spring"

New vaccine against deadly meningitis B 'will be available in the spring' Meningitis B causes 120 deaths in Britain each yearVaccine effective against about 80 per cent of strains found in Europe A new vaccine against meningitis B gives full protection to teenagers, according to the first large-scale trial and could be available this Spring.